FeesSafety
Pluang+

Coherus Oncology to release Q3 2026 financial results on Nov 9 with a live webcast and call.

Company Fundamentals
26 Oct 2026, 16:30 WIB
GlobeNewsWire
View Source
Neutral
Coherus Oncology to release Q3 2026 financial results on Nov 9 with a live webcast and call.

Coherus Oncology announced it will report its third quarter 2026 financial results on November 9, 2026. The company will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the results and provide a business update. Investors can access the call by pre-registering online, and a replay will be available on Coherus' investor website. This update is important as Coherus continues to advance its oncology pipeline, including its approved PD-1 inhibitor LOQTORZI and two clinical candidates targeting various cancers.

Coherus Oncology's upcoming Q3 2026 financial results offer context for readers. For those tracking health-sector stocks, 89 of 150 priced US health-sector stocks on Pluang rose today while 50 fell. Notable movers include ABEO at USD 4.54 (+3.18%), ACB at USD 3.76 (-3.09%), and MRVI at USD 7.11 (-2.87%). This data is as of Oct 26, 2026 20:32 WIB.

More News

Smithfield Foods launches $250K scholarship for business students at Christopher Newport University

Smithfield Foods launches $250K scholarship for business students at Christopher Newport University

Smithfield Foods has created a $250,000 Future Leaders Scholarship program at Christopher Newport University to support eight incoming business students with $7,500 annual scholarships renewable for up to four years. The program aims to help local st...

Others
Bullish
1 hour ago
E-Power's Guizhou JV secures RMB 110M of RMB 200M capital raise, valuing it at RMB 2B post-money.

E-Power's Guizhou JV secures RMB 110M of RMB 200M capital raise, valuing it at RMB 2B post-money.

E-Power Inc.'s joint venture, Sunrise Guizhou, received RMB 110 million of a planned RMB 200 million capital increase, raising its registered capital and valuing the company at RMB 2 billion post-money. The funds will support business expansion, R&D,...

Company Fundamentals
Bullish
1 hour ago
Tallinna Sadam secures €50M loan to refinance bonds maturing in 2026, extending debt to 2031.

Tallinna Sadam secures €50M loan to refinance bonds maturing in 2026, extending debt to 2031.

AS Tallinna Sadam has signed a €50 million unsecured loan agreement with Swedbank, with a 5-year term and interest based on 3-month Euribor plus a margin. The loan will be fully drawn on October 26, 2026, and matures on October 26, 2031. This financi...

Company Fundamentals
Neutral
2 hours ago
AS Tallinna Sadam secures €50M loan to redeem bonds, supporting port operations and growth.

AS Tallinna Sadam secures €50M loan to redeem bonds, supporting port operations and growth.

AS Tallinna Sadam signed a €50 million unsecured loan agreement with AS Swedbank, maturing in five years with an interest rate based on 3-month Euribor plus margin. The loan, drawn on October 26, 2026, will be used to redeem bonds worth €50.4 million...

Company Fundamentals
Neutral
2 hours ago
Vita Coco and Homesick launch limited-edition candles inspired by Vita Coco Treats flavors

Vita Coco and Homesick launch limited-edition candles inspired by Vita Coco Treats flavors

Vita Coco, a leading coconut water brand, has partnered with Homesick to create a limited-edition candle collection inspired by Vita Coco Treats flavors: Strawberries & Creme and Frosted Lemonade. The candles capture the essence of these flavors thro...

Others
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App